...
机译:Protroca:在NONERECTED乳腺癌患者中对化疗诱导的化疗诱导的中性粒细胞缺乏症的预防措施研究
Univ Munich LMU Dept Obstet &
Gynecol Breast Ctr Munich Germany;
Univ Munich LMU Dept Obstet &
Gynecol Breast Ctr Munich Germany;
Univ Clin Tubingen Womens Clin Tubingen Germany;
Univ Canc Ctr Leipzig UCCL Univ Clin Leipzig Leipzig Germany;
Evangel Hosp Bethesda Breast Ctr Niederrhein Ludwig Weber Str 15 DE-91061 Monchengladbach;
Breast Ctr Clin Chemnitz Chemnitz Germany;
Franziskus Hosp Harderberg Niels Stensen Clin Georgsmarienhutte Germany;
Breast Ctr Altmark Johanniter Clin Stendal Stendal Germany;
Med Ctr Hematol &
Oncol Munich Munich Germany;
MVZ Nordhausen Nordhausen Germany;
Breast Ctr Municipal Clin Karlsruhe Karlsruhe Germany;
Practice Network Troisdorf Troisdorf Germany;
Breast Ctr Donau Isar Clin Deggendorf Deggendorf Germany;
Gynecol Oncol Practice Hanover Hannover Germany;
Univ Clin Munster Breast Ctr Munster Germany;
West German Study Grp Monchengladbach Germany;
West German Study Grp Monchengladbach Germany;
West German Study Grp Monchengladbach Germany;
West German Study Grp Monchengladbach Germany;
Lipegfilgrastim; Chemotherapy; Breast cancer; Febrile neutropenia prophylaxis;
机译:Protroca:在NONERECTED乳腺癌患者中对化疗诱导的化疗诱导的中性粒细胞缺乏症的预防措施研究
机译:在2489例癌症患者中,用LipegfilGrastim的化疗诱导的中性粒细胞率和Feberile Neveropenia的预防:非介入研究Nadir的最终结果
机译:Lipegfilgrastim与Pegfilgrastim相比于II-IV期乳腺癌患者预防化疗诱导的中性粒细胞减少的成本-效用分析
机译:预防性抗生素对化疗后化学性中性蛋白发热后癌症患者ANC Valys and Heation的作用
机译:一级预防中性粒细胞减少对老年接受化疗的乳腺癌患者的结局,利用和支出的影响。
机译:Lipegfilgrastim与Pegfilgrastim相比在II-IV期乳腺癌患者中预防化疗引起的中性粒细胞减少的成本效用分析
机译:Lipegfilgrastim与Pegfilgrastim相比在II-IV期乳腺癌患者中预防化疗引起的中性粒细胞减少的成本效用分析
机译:乳腺癌化疗治疗患者的心理应激,中性粒细胞减少和传染病